JOHNSON & JOHNSON
NYSE: JNJ
▼
162.00
-6.23
-3.70%
1 Day
-
Open
167.93
-
Previous Close
168.23
-
Volume (Avg)
23.26M (6.13M)
-
Day's Range
161.08-168.54
-
52Wk Range
155.72-186.69
-
Market Cap.
423.55B
-
Dividend Rate (Yield)
4.52 (2.69%)
-
Beta
-
-
Shares Outstanding
-
-
P/E Ratio (EPS)
24.96 (-)
Top Stories
-
Why Johnson & Johnson Stock Slipped by Nearly 4% on Monday
The Motley Fool 1 hr ago -
Johnson & Johnson can't invoke bankruptcy to stop cancer lawsuits, court says
ABC News -
Boris Johnson says Putin threatened to ‘hurt’ him with missile strike after visiting Ukraine
FOX News -
Johnson and Johnson loses $17 billion in market value after appeals court denies company bankruptcy escape in baby powder lawsuits
Markets Insider -
Court tosses bankruptcy petition by Johnson & Johnson's talc unit
FOX News 3 hrs ago -
Why the Jets Should Change Jermaine Johnson's Position
Jets Country on FanNation -
Ju'Juan Johnson Names Florida in Final 3, Sets Commitment Date
All Gators on FanNation -
Even On One Leg, Lane Johnson Helps Shut Down Nick Bosa
Eagle Maven on FanNation -
Kremlin denies Boris Johnson's claim of Putin threatening missile strike
Washington Examiner -
January 6th rioter accused of secretly recording Iowa woman in tanning salon
WHO-TV Des Moines -
Johnson & Johnson’s Attempt to Contain Talc-Related Liabilities Is Rebuffed
The New York Times -
Johnson & Johnson Shares Drop as Court Rejects Use of Bankruptcy in Talc Lawsuits
Barron's -
Ex-NFL player Charles Johnson, whose death was ruled a suicide, deserves to be remembered| Opinion
USA Today -
A look back at Lyndon B. Johnson's space legacy, 50 years after his death
Space.com -
Johnson & Johnson fourth-quarter earnings down 25%
Fox Business 6 days agoJohnson & Johnson reported a 25% drop in earnings and declining sales for the fourth quarter as demand dropped for its Covid-19 vaccine, while providing a cautious forecast for sales growth as the ...
-
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
The Motley Fool -
Johnson & Johnson slashes production of COVID vaccine amid drop in demand
NJ.com -
Johnson & Johnson, 3M stocks down on ‘Texas two-step’ decision
MassDevice
